Severe neurological symptoms: In cases of advanced deficiency with symptoms such as tingling, numbness, gait instability or memory problems, a rapid and high dose is necessary to prevent permanent nerve damage
[NCBI] C.-H
In monotherapy trials with semaglutide oral tablets for T2DM, severe hypoglycemia (requiring the assistance of another person) was reported in 1% of patients receiving the 7 mg tablets and 0% of patients receiving the 14 mg tablets or placebo
Research Handling Guidance In published research protocols, BAC water is typically added to lyophilised peptide vials in controlled volumes, with the vial swirled gently not shaken until fully dissolved
The solution should be clear once dissolved
The standard format is an 80 mg vial split as 50 mg GHK-Cu, 10 mg KPV, 10 mg BPC-157, and 10 mg TB-500